Skip to content
MedCompare

Bortezomib

Also known as Velcade (us), Bortenat (india)

Cancer & Oncology
Save $7,018/mo
10× cheaper

Bortezomib is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system).

United States
$7,838
per month
India
$820
per month
You save
$7,018
90% cheaper in India
4.5K US scripts/yr$31.3M potential annual savings$35M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC19H25BN4O4

SMILES: B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O

Compare the price
US price$7,838per month
India price$820per month
You save$7,01890% less

Based on 30 units per month. US $261.26 vs India $27.32 per unit.

Total over 1 periodSave $7,018$7,838 → $820
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$42,109
Estimated travel cost
− $2,300
Net savings after travel
$39,809

Even after travel, you could come out ahead by about $39,809.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Bortezomib is filled about 4.5K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$35M
If sourced from India
$3.7M
Potential annual savings
$31.3M
−90%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.